CEPTUGRO
Eli Lilly and Company
Application Filed: 2015-11-12
Trademark Application Details
Mark For: CEPTUGRO™ trademark registration is intended to cover the categories of
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86817774 |
| Mark Literal Elements | CEPTUGRO |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | INTENT TO USE SECTION 2016-12-19 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Bruce W. Longbottom |
| Attorney Name | Bruce W. Longbottom |
| Law Office Assigned | M10 |
| Employee Name | KHOURI, SANI PHILIPPE |
Timeline
| 2015-11-12 | Application Filed |
| 2016-05-03 | Published |
| 2016-05-03 | Published for Opposition |
| 2016-12-19 | Location: INTENT TO USE SECTION |
| 2019-07-29 | Abandon |
| 2019-07-29 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
| 2019-07-29 | Status: Dead/Abandoned |
| 2019-07-29 | Transaction Date |
Trademark Parties (Applicants & Owners)
| Party: |  Eli Lilly and Company |
| Address | Lilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285 |
| Legal Entity Type | Corporation |
| Legal Entity State | INDIANA |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-07-29 | |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-07-29 | 99999 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-11-27 | |
| EXTENSION 5 GRANTED | 2018-11-26 | 66154 |
| TEAS EXTENSION RECEIVED | 2018-11-20 | |
| EXTENSION 5 FILED | 2018-11-20 | 66154 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-06-15 | |
| EXTENSION 4 GRANTED | 2018-06-14 | 66154 |
| TEAS EXTENSION RECEIVED | 2018-06-13 | |
| EXTENSION 4 FILED | 2018-06-13 | 66154 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-11-23 | |
| TEAS EXTENSION RECEIVED | 2017-11-21 | |
| EXTENSION 3 GRANTED | 2017-11-21 | 98765 |
| EXTENSION 3 FILED | 2017-11-21 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-06-23 | |
| EXTENSION 2 GRANTED | 2017-06-22 | 66154 |
| TEAS EXTENSION RECEIVED | 2017-06-02 | |
| EXTENSION 2 FILED | 2017-06-02 | 66154 |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-03-09 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-03-09 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-12-29 | |
| EXTENSION 1 GRANTED | 2016-12-28 | 66154 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-12-19 | 66154 |
| TEAS EXTENSION RECEIVED | 2016-11-29 | |
| EXTENSION 1 FILED | 2016-11-29 | 66154 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-06-28 | |
| PUBLISHED FOR OPPOSITION | 2016-05-03 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-05-03 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-04-13 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-03-28 | 68171 |
| ASSIGNED TO LIE | 2016-03-25 | 68171 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-03-10 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2016-03-10 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2016-03-10 | 77986 |
| EXAMINER'S AMENDMENT ENTERED | 2016-03-10 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-03-10 | |
| ASSIGNED TO EXAMINER | 2016-03-06 | 77986 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-11-17 | |
| NEW APPLICATION ENTERED IN TRAM | 2015-11-16 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CEPTUGRO 88462788 not registered Live/Pending |
Eli Lilly and Company 2019-06-06 |
 CEPTUGRO 86817774 not registered Dead/Abandoned |
Eli Lilly and Company 2015-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 